| abstract |
Compounds of the formula and the dotted lines represent optional additional CC bonds with E or Z configuration and the other symbols have the meaning given in claim 1, and pharmaceutically acceptable salts thereof have mucosa-protective and gastric acid secretion-inhibiting properties and can be used for the treatment of ulcer ventriculi and / or duodeni. They are new, with the exception of 10-hydroxy-3,7,11-trimethyl-2,6,11-dodecatrienoic acid and 3,7,11-trimethyl-2,6,11-dodecatrien-1,10-diol. They can be processed into pharmaceutical dosage forms and manufactured using various processes. |